Pet Diabetes Care Market Report Scope & Overview:

The pet diabetes care market size was valued at USD 2.07 billion in 2024 and is expected to reach USD 4.08 billion by 2032, growing at a CAGR of 8.87% over the forecast period of 2025-2032. 

The increasing incidence of diabetes in pets due to obesity, sedentary lifestyle, and longer life span escalates the demand for insulin, glucose monitors, and prescription diets, thereby driving the global pet diabetes care market. The pet diabetes care market trends, including family and the rising spending on advanced treatments due to an increased awareness about pet humanization, will further influence the growth of the pet diabetes care market, along with growing demand for devices, including continuous glucose monitoring and specialized nutrition, improvements in veterinary infrastructure globally, and expanded health care access.

For instance, in January 2025, Boehringer Ingelheim reported that ~1 in 200 cats and 1 in 300 dogs have diabetes globally, with prevalence rising approximately 6% annually.

Key Pet Diabetes Care Market Trends

• Expansion of specialized therapies: Increasing development of innovative insulin formulations, oral antidiabetic supplements, and continuous glucose monitoring for dogs and cats.

• Integration of smart devices: Adoption of wearable glucose monitors, smart insulin pens, and app-based tracking to improve accuracy and compliance.

• Focus on personalized care: Tailored diabetes management considering pet species, age, weight, and lifestyle for optimized therapeutic outcomes.

• Collaboration across stakeholders: Partnerships between veterinary clinics, biotech firms, and pet healthcare CDMOs for product co-development and technology transfer.

• Novel delivery platforms: Introduction of sustained-release insulin, Glucose Monitoring Devices patches, and oral gels for convenient, stress-free diabetes management.

• Growing awareness and regulatory support: Enhanced veterinary guidance, clinical trials, and stronger regulatory frameworks boosting confidence in diabetes care solutions.

Pet Diabetes Care Market Report Highlights

The U.S. pet diabetes care market was valued at USD 727.33 million in 2024 and is expected to reach USD 1414.86 million by 2032, growing at a CAGR of 8.69% over 2025-2032. According to the pet diabetes care market analysis, pet ownership is high, along with an expanding humanization in the U.S. High adoption and care of pets create robust demand for an advanced diabetes management system that includes insulin, glucose monitoring, and a specialized diet. High awareness, penetration of vet services, and propensity to spend on pet health drive growth in the U.S., making it the largest contributor globally.

Pet Diabetes Care Market Growth Drivers:

• Expansion of Veterinary Infrastructure & Telemedicine is Driving the Pet Diabetes Care Market Growth

Expanding veterinary infrastructure and telemedicine are the key drivers of the pet diabetes care market share. nowadays, the global increase in the number of veterinary endocrinologists and specialty clinics seems to be enhancing patient care for diagnosing and treating diabetes. Moreover, tele-veterinary services enable pet owners to keep a tab on the health of their pets over remote locations, which ensures better compliance with treatment and helps create greater adoption in multiple regions.

For instance, in February 2025, TeleVet Insights reported that remote consultations for chronic pet conditions, including diabetes, grew 18% in the U.S., improving home monitoring and treatment adherence.

Pet Diabetes Care Market Restraints:

• Limited Awareness in Certain Regions is Hampering the Pet Diabetes Care Market Growth

The pet diabetes care market growth is limited by a lack of awareness. Symptoms of the disease and early detection methods, plus different health protocols through which we can manage diabetes, are not something many pet owners are familiar with. Low awareness hinders diagnostic and treatment, reduces uptake of advanced therapy, and limits the growth in the market, even with increased prevalence & technological breakthroughs.

Pet Diabetes Care Market Opportunities:

• Advanced Glucose Monitoring Technologies Drive Future Growth Opportunities for the Pet Diabetes Care Market

The pet diabetes care market is experiencing large opportunities from the deployment of CGM and wearables. These technologies enable people to track their dog or cat's glucose levels in real time so they can adjust their insulin as needed, which can then contribute to fewer complications and better overall management of the disease. Veterinarians and pet owners receive prescriptive insights through analytics, which will improve compliance and outcomes.

For instance, in March 2025, Innovative insulin delivery methods, including Glucose Monitoring device patches, sustained-release injections, and oral gels, are enhancing pet compliance and simplifying diabetes management.

Key Pet Diabetes Care Market Segment Analysis

• By type, dogs held the largest share of around 68.80%in 2024, and the cats segment is expected to register the highest growth with a CAGR of 9.17%.

• By solution, the treatment segment dominated the market with approximately 85.53% share in 2024, while glucose monitoring devices are expected to register the highest growth with a CAGR of 9.80%

• By distribution channel, veterinary hospitals & clinics accounted for the leading share of nearly 42.76% in 2024, while e-commerce development is expected to register the highest growth with a CAGR of 9.53%.

• By end user, the veterinary hospitals & clinics segment led the market with about 72.80% share in 2024, while the home-care settings segment is forecasted to grow the fastest at a CAGR of 9.23%.

By Type, Dogs Lead the Market, While Cats Register Fastest Growth

The dogs segment accounted for the highest revenue share of approximately 68.80% in 2024, as more dogs develop diabetes than cats, including the growing prevalence of obesity, upsurge in pet humanization, and increased owner awareness about the management of diabetes in dogs. In comparison, the cats segment is anticipated to achieve the highest CAGR of nearly 9.17% during the 2025–2032 period, driven by higher consumption in cats can be partially explained by increased feline diabetes, and also cat owners paying more attention to the health of their pets.

By Solution, the Treatment Segment dominates, while the Glucose Monitoring Devices Segment Shows Rapid Growth

The treatment segment held the largest revenue share of approximately 85.53% in 2024, as it covers insulin therapy, continuous glucose monitoring, and prescription diets that are necessary in the treatment of diabetes in pets. The dominance factors include a growing pet population of diabetic patients, increased humanization of pets. On the other hand, the glucose monitoring devices segment is predicted to grow at the strongest CAGR of approximately 9.80% during 2025–2032, owing to meet the growing market need for home diabetes care. Driving factors are increasing awareness of early detection, adoption of pet-specific monitoring systems, including AlphaTRAK and PetTest.

By Distribution channel, Veterinary Hospitals & Clinics Segment Lead, While E-Commerce Development Registers Fastest Growth

The veterinary hospitals & clinics segment accounted for the largest share of the pet diabetes care market with about 42.76%, as they offer complete evaluation and control of diabetes. This includes the widening availability of specialist veterinary care, access to trained endocrinologists, and the use of advanced diagnostic tools, growing pet humanization trends. In addition, the E-Commerce development segment is slated to grow at the fastest rate with a CAGR of around 9.53% throughout the forecast period of 2025–2032, owing to the online channel for buying insulin, glucose monitors, and diabetic pet diets continuing to grow. Convenience, broader availability of products, home delivery, and rising digital literacy in pet owners. 

By End User, Veterinary Hospitals & Clinics Segment Lead, While the Home-care Settings Segment Grows the Fastest

The veterinary hospitals & clinics segment held the largest revenue share of around 72.80% in the pet diabetes care market in 2024, owing to the provision of supportive-design diabetes management comprising diagnosis, treatment, and monitoring. Dominance of veterinary clinics, owing to the presence of veterinarians trained for specialized medication and the availability of advanced diagnostic tools. On the flip side, the home-care settings segment, however, is projected to register the highest CAGR of around 9.23% during the forecast period of 2025 - 2032, driven by the expanding usage of at-home diabetes care. The growth of the market is largely driven by factors, including increased adoption of companion animals, preventative and health-checkup by glucose monitoring tech awareness among pet owners.

Asia Pacific Pet Diabetes Care Market Insights

Asia-Pacific is the fastest-growing segment in the pet diabetes care market with a CAGR of 9.74%, driven by higher pet ownership, urbanization, and disposable incomes, resulting in owners paying more for quality pet healthcare. Highly efficient growth factors for pet diabetes care awareness and diagnostics in Veterinary infrastructure that incorporates advanced treatments, including Insulin therapy, Glucose monitoring devices, and Prescription Diet & Nutrition, are spurring the industry potential. Advancement of the e-commerce and tele-veterinary services provides diabetic care products easier access. Rise in pet humanization across Asia-Pacific, along with transition towards preventive healthcare practices, is resulting in increased demand for canine influenza vaccine, leading to the region being the fastest-growing regional market globally.

North America Pet Diabetes Care Market Insights

North America accounted for the highest revenue share of approximately 41.72% in 2024 of the pet diabetes care market, owing to the high pet population, highly humanized pets, and developed veterinary infrastructure. The area is well served with insulin, glucose monitoring devices, prescription diets, and surrounded by specialty veterinary clinics and trained endocrinologists. Furthermore, rising awareness among pet owners, the inclination towards at-home monitoring, paired with good insurance coverage for pets, adds fuel to the demand in North America, which makes it dominate as a revenue generator over the regional zone across the global market.

Europe Pet Diabetes Care Market Insights

Europe is holding the second-largest market share of the pet diabetes care market, owing to the number of pets and pet owners who are more aware of how to treat diabetes, and are receiving veterinary care and specialized diets. Europe is considered to be a major contributor to the ADA market, triggering in rapidly changing healthcare sector, better insurance policies with superior benefits and offers, and Europe after first Americas.

Latin America (LATAM) and Middle East & Africa (MEA) Pet Diabetes Care Market Insights

The pet diabetes care market in these regions is primarily driven by a higher concentration of pets, awareness about pet health, and availability of better care facilities for pets animals.  Urbanization and increasing disposable incomes are pushing for better diabetes control and management and driving demand for more sophisticated diabetes control solutions, including insulin products, glucose measurement devices, and diabetes-friendly pet foods.

Competitive Landscape for the Pet Diabetes Care Market:

Boehringer Ingelheim is also leading in the area of Animal Health with scientific and research-based products for apescent veterinary care. Their R&D focus and international footprint further enhance our ability to manage pet health and our portfolio of advanced therapeutics.

• In June 2024, Boehringer launched a next-generation continuous glucose monitoring system for pets, improving real-time diabetes management and owner compliance globally.

Merck provides innovation-driven, high-quality medicines to help improve the health of animals, with insulin and monitoring products for pets. Significant investment in veterinary research and digital tools enables better diabetes control in pets globally.

• In September 2024, Merck introduced an innovative sustained-release insulin formulation for dogs, reducing injection frequency and enhancing glycemic control in veterinary practices.

Elanco offers a wide range of products for diabetes management in pets, nutrition, and therapy. Strategic alliances and technology application increase access to and the efficacy of therapy in global markets.

• In March 2025, Elanco partnered with a biotech firm to co-develop oral antidiabetic supplements for cats and dogs, targeting personalized and species-specific diabetes management.

Pet Diabetes Care Market Key Players:

Some of the pet diabetes care market companies are:

• Boehringer Ingelheim Animal Health

• Merck Animal Health

• Elanco Animal Health

• Zoetis Inc.

• Ceva Santé Animale

• Dechra Pharmaceuticals PLC

• Nestlé Purina PetCare

• Hill’s Pet Nutrition

• Royal Canin

• Farmina Pet Foods

• Abbott Laboratories

• AlphaTRAK

• BD 

• i-SENS, Inc.

• Taiwan Ostor Corp.

• ARKRAY, Inc.

• Nova Biomedical

• Henry Schein Animal Health

• PetTest 

• Trividia Health, Inc.